KYSO antibody medicines

EUIPO EUIPO 2022 Trademark registered

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The Union trademark KYSO antibody medicines was filed as Word mark on 05/24/2022 at the European Union Intellectual Property Office.
It was registered as a trademark on 09/27/2022. The current status of the mark is "Trademark registered".

Trademark Details Last update: February 9, 2024

Trademark form Word mark
File reference 018707820
Application date May 24, 2022
Publication date June 20, 2022
Entry date September 27, 2022
Expiration date May 24, 2032

Trademark owner

Carl Jacobsens Vej 30
2500 Valby
DK

Trademark representatives

Axeltorv 2 1609 Copenhagen V DK

goods and services

1 Chemical, biochemical, biological, and biotechnological preparations, especially antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for in vitro and in vivo scientific and industrial research and development with regard to diseases; active chemical ingredients for use in the manufacture of pharmaceuticals
5 Pharmaceutical and veterinary preparations, including pharmaceutical preparations based on antibodies, and bi- and multispecific antibodies as well as fragments, including monovalent antibodies, derivatives or conjugates of any of these for use with regard to diseases
42 Medical, scientific and biological research, especially research into antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these and development of pharmaceutical products based on antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these; chemical analysis; computer programming, namely programming of computers for the collection and processing of medical data in medical scientific research, development and therapy, including scientific research, development and therapy with antibodies and bi- and multispecific antibodies or fragments, including monovalent antibodies, derivatives or conjugates of any of these
45 Patent exploitation and licensing of intellectual property in the field of medicine

Trademark history

Date Document number Area Entry
August 17, 2023 Transfer / Change of address, Published

ID: 11018707820